Elutia is thrilled to announce that we have successfully raised $15,000,000 in our latest funding round鈥攁 decisive step forward in our mission to humanize medicine so that patients can thrive without compromise. This significant investment not only underscores the confidence of our investors in our vision but also fuels our commitment to redefining the landscape of healthcare delivery. At Elutia, we believe that patient wellbeing should always be at the heart of medical innovation, and this new capital will enable us to accelerate the development of groundbreaking technologies and personalized treatment solutions that empower individuals to take control of their health. With these funds, we will invest in advanced research and development programs, expand our state-of-the-art facility, and enhance our team with top-tier talent, all aimed at creating a more compassionate and efficient healthcare ecosystem. Moreover, the funding will help us forge important partnerships with healthcare professionals and industry leaders, ensuring that our innovations reach those in need more quickly and effectively. By bridging technology with human-centric care, we are poised to transform traditional healthcare practices, offering patients not just treatment but a holistic approach that nurtures and sustains life. This journey is not only about technological advancements but also about rebuilding trust in medicine and making compassionate care accessible to all. As we embark on this exciting new chapter, we remain fully dedicated to our core belief: every patient deserves the opportunity to thrive, and through our continued innovation and unwavering commitment, we will help make that vision a reality.
Elutia Raises $15M to Humanize Medicine鈥擡mpowering Patients to Thrive Without Compromise
Recently funded 路 $15.0MMedical Devices
Get the full Elutia company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Indemni
Indemni protects freight brokers and 3PLs from non-compliance and strategic theft using identity and fraud prevention tools. Their risk compliance solution automates carrier and driver checks, validates CDL credentials against DMV/DOT, and real-time tracks cargo鈥攊dentifying 8% of dispatched drivers as non-compliant.
$4.0M Seed
today
BioLinker
BioLinker is a biotechnology and synthetic biology startup created by scientists, for scientists. We develop innovative solutions, services, and research kits for academic and industrial applications involving proteins, helping laboratories and companies accelerate research and development with greater practicality, quality, and reliability. Our work is based on cell-free protein synthesis technology (CFPS), a fast and flexible approach for protein expression that enables shorter development cycles and supports a wide range of scientific and industrial applications. By combining experimental expertise in protein science with data-driven and AI-supported approaches, we aim to make protein development faster, more predictable, and more accessible for research and industry. More than a service provider, BioLinker acts as a proactive scientific partner, supporting clients with technical expertise, personalized guidance, and continuous assistance throughout their projects. To learn more about BioLinker, our technologies, products, and services, visit our website, follow us on social media, or contact one of our representatives. We look forward to supporting the development of your projects.
